Status:
UNKNOWN
Observational Study on the Improvement of Dry Eye Syndrome, Treatment Satisfaction, and Intraocular Tolerance With Diquasol Eye Drops
Lead Sponsor:
Hanlim Pharm. Co., Ltd.
Conditions:
Dry Eye Syndrome
Eligibility:
All Genders
19+ years
Brief Summary
This study is to verify the efficacy and safety in the treatment of dry eye syndrome in patients prescribed with Diquasol eye drops as a monotherapy, or in combination with Hyaluron eye drops, or in c...
Detailed Description
This study is to observe the prescription patterns in routine clinical practice and assess the changes in dry eye symptoms, treatment satisfaction, and intraocular tolerance over a 12-week period in p...
Eligibility Criteria
Inclusion
- Adults aged 19 years and older
- Patients with dry eye syndrome with TBUT of 10 or less
- Individuals scheduled to receive either Diquasol eye drops as a monotherapy or a combination therapy of Diquasol eye drops with Hyaluron eye drops or Diquasol eye drops with Hyaluronmax eye drops, based on clinical judgment for the treatment of dry eye syndrome
- Individuals who have voluntarily provided written consent for participation in this study
Exclusion
- Pregnant or lactating women
- Individuals contraindicated according to the approval conditions of Diquasol eye drops, Hyaluron eye drops, and Hyaluronmax eye drops
- Cases where the principal investigator or study personnel deem the individual unsuitable for participation in this clinical study
Key Trial Info
Start Date :
February 8 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT06172530
Start Date
February 8 2023
End Date
December 1 2024
Last Update
December 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CK St. Mary's Eye Clinic
Seoul, South Korea, 06531